Associations of antimicrobial uses with antimicrobial resistance of fecal Escherichia coli from pigs on 47 farrow-to-finish farms in Ontario and British Columbia

Canadian Journal of Veterinary Research

Volumn 72, Issue 2 SPEC. ISS., 2008, Pages 202-210

  Akwar, Holy T ^a,e   Poppe, Cornelis ^b   Wilson, Jeff ^a,b   Reid Smith, Richard J ^a,b   Dyck, Monica ^c   Waddington, Josh ^d   Shang, Dayue ^c   McEwen, Scott A ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c Health Canada and World Health Organization Collaborating Center for Standardization and Evaluation of Biologicals   (Canada)

^d Animal Health Centre   (Canada)

^e BC MAFF ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; APRAMYCIN; CARBADOX; CEFTIOFUR; GENTAMICIN; LINCOMYCIN; NEOMYCIN; PENICILLIN DERIVATIVE; SPECTINOMYCIN; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE; TIAMULIN; TYLOSIN;

AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CANADA; CONTROLLED STUDY; CROSS RESISTANCE; ESCHERICHIA COLI; FECES MICROFLORA; FREQUENCY ANALYSIS; INDEPENDENT VARIABLE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NONHUMAN; PHENOTYPIC VARIATION; PIG FARMING;

AGE FACTORS; ANIMAL FEED; ANIMALS; ANTI-BACTERIAL AGENTS; BRITISH COLUMBIA; COLONY COUNT, MICROBIAL; DISEASE RESERVOIRS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; FECES; FEMALE; LOGISTIC MODELS; MALE; MICROBIAL SENSITIVITY TESTS; ONTARIO; PREVALENCE; RISK FACTORS; SWINE;

ESCHERICHIA COLI; SUIDAE;

EID: 44649083284     PISSN: 08309000     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. FAO/OIE/WHO. Joint FAO/OIE/WHO workshop on non-human antimicrobial usage and antimicrobial resistance: Scientific assessment. Geneva, 1-5 December 2003. Geneva, World Health Organization, 2004.
2. O'Brien TF. Emergence, spread, and environmental effect of antimicrobial resistance: How use of an antimicrobial anywhere can increase resistance to any antimicrobial anywhere else. Clin Infect Dis 2002;34:S78-84.
3. Jensen VF, Jakobsen L, Emborg HD, Seyfarth AM, Hammerum AM. Correlation between apramycin and gentamicin use in pigs and an increasing reservoir of gentamicin-resistant Escherichia coli. J Antimicrob Chernother 2006;58:101-107.
4. Wegener HC, Aarestrup FM, Jensen LB, Hammerurn AM, Bager F. Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe. Emerg Infect Dis 1999;5:329-335.
5. Rajić A, Reid-Smith R, Deckert AE, Dewey CE, McEwen SA. Reported antibiotic use in 90 swine farms in Alberta. Can Vet J 2006;47:446-452.
6. USDA. 2002. Part II. Reference of swine health and health management in the United States, 2000. USDA:APHIS:VS, CEAH, National Animal Health Monitoring System, Fort Collins, CO. #N355.0202.
7. Dunlop RH, McEwen SA, Meek AH, Clarke RC, Black WD, Friendship RM. Associations among antimicrobial drug treatments and antimicrobial resistance of fecal Escherichia coli of swine on 34 farrow-to-finish farms in Ontario, Canada. Prev Vet Med 1998;34:283-305.
8. Kim LM, Gray JT, Harmon BG, Jones RD, Fedorka-Cray PJ. Susceptibility of Escherichia coli from growing piglets receiving antimicrobial feed additives. Foodborne Pathog Dis. 2005;2: 304-316.
9. Bunner CA, Norby B, Bartlett PC, Erskine RJ, Downes FP, Kaneene JB. Prevalence and pattern of antimicrobial susceptibility in Escherichia coli isolated from pigs reared under antimicrobial-free and conventional production methods. J Am Vet Med Assoc 2007;15:231,275-283.
10. Bager F. DANMAP: Monitoring antimicrobial resistance in Denmark. Int J Antimicrob Agents 2000;14:271-274.
11. Akwar HT, Poppe C, Wilson J, et al. Prevalence and patterns of antimicrobial resistance of fecal Escherichia coli among pigs on 47 farrow-to-finish farms with different in-feed medication policies in Ontario and British Columbia. Can J Vet Res 2008;72: 195-201.
12. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-130.
13. World Health Organization. International Review Panel Evaluation of the Tennination of the Use of Antimicrobial Growth Promoters in Denmark. World Health Organization: Geneva, Switzerland, 2003.
14. Aarestrup FM, Wegener HC. The effects of antibiotic usage in food animals on the development of antimicrobial resistance of importance for humans in Campylobacter and Escherichia coli. Microbes Infect 1999;1:639-644.
15. Dewulf J, Catry B, Timmerman T, Opsomer G, de Kruif A, Maes D. Tetracycline-resistance in lactose-positive enteric coliforms originating from Belgian fattening pigs: Degree of resistance, multiple resistance and risk factors. Prev Vet Med 2007;78:339-351.
16. Werner G, Hildebrandt B, Witte W. Aminoglycoside-streptothricin resistance gene cluster aadE-sat4-aphA-3 disseminated among multiresistant isolates of Enterococcus faecium. Antimicrob Agents Chemother 2001;45:3267-3269.
17. Schwarz S, Chaslus-Dancla E. Use of antimicrobials in veterinary medicine and mechanisms of resistance. Vet Res 2001;32: 201-225.
18. Health Canada. Uses of Antimicrobials in Food Animals in Canada: Impact on Resistance and Human Health. 2002:55-58.
19. Harada K, Asai T, Kojima A, Sameshima T, Takahashi T. Contribution of multi-antimicrobial resistance to the population of antimicrobial resistant Escherichia coli isolated from apparently healthy pigs in Japan. Microbiol Immunol 2007;51:493-499.
20. Harada K, Asai T, Kojima A, Ishihara K, Takahashi T. Role of coresistance in the development of resistance to chloramphenicol in Escherichia coli isolated from sick cattle and pigs. Am J Vet Res 2006;67:230-235.
21. Delsol AA, Anjum M, Woodward MJ, Sunderland J, Roe JM. The effect of chlortetracycline treatment and its subsequent withdrawal on multi-resistant Salmonella enterica serovar Typhimurium DT104 and commensal Escherichia coli in the pig. J Appl Microbiol 2003;95:1226-1234.